Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To evaluate the feasibility, effectiveness and safety of chidamide combined with venetoclax and azacitidine in the treatment of newly diagnosed acute myeloid leukemia (AML) who are not suitable for intensive chemotherapy.
Epistemonikos ID: 04b9372508a80907d7db89666a31c747bb3fd4f4
First added on: May 16, 2024